XML 27 R10.htm IDEA: XBRL DOCUMENT v3.22.0.1
Fair Value Measurements
12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements

NOTE 6—Fair Value Measurements

The fair value hierarchy gives the highest priority to quoted prices in active markets (Level 1) and the lowest priority to unobservable data (Level 3).  In some cases, the inputs used to measure fair value might fall in different levels of the fair value hierarchy.  The lowest level input that is significant to a fair value measurement in its entirety determines the applicable level in the fair value hierarchy.  Assessing the significance of a particular input to the fair value measurement in its entirety requires judgment, considering factors specific to the asset or liability.

The following table summarizes our financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2021 and 2020:  

 

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

 

 

 

 

 

 

 

in Active

 

 

Significant

 

 

 

 

 

 

 

 

 

 

Markets for

 

 

Other

 

 

Significant

 

 

 

 

 

 

Identical

 

 

Observable

 

 

Unobservable

 

 

December 31,

 

 

Assets

 

 

Inputs

 

 

Inputs

 

 

2021

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

(in thousands)

 

Nuclear decommissioning trust (1)

$

89,227

 

 

$

89,227

 

 

$

 

 

$

 

Nuclear decommissioning trust - net asset value (1)(2)

 

187,431

 

 

 

 

 

 

 

 

 

 

Unrestricted investments and other (3)

 

212

 

 

 

 

 

 

212

 

 

 

 

Derivatives - gas and power (4)

 

50,793

 

 

 

32,078

 

 

 

3,705

 

 

 

15,010

 

Total Financial Assets

$

327,663

 

 

$

121,305

 

 

$

3,917

 

 

$

15,010

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives - gas and power (4)

$

4,291

 

 

$

 

 

$

4,291

 

 

$

 

Total Financial Liabilities

$

4,291

 

 

$

 

 

$

4,291

 

 

$

 

 

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

 

 

 

 

 

 

 

in Active

 

 

Significant

 

 

 

 

 

 

 

 

 

 

Markets for

 

 

Other

 

 

Significant

 

 

 

 

 

 

Identical

 

 

Observable

 

 

Unobservable

 

 

December 31,

 

 

Assets

 

 

Inputs

 

 

Inputs

 

 

2020

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

 

(in thousands)

 

Nuclear decommissioning trust (1)

$

76,037

 

 

$

76,037

 

 

$

 

 

$

 

Nuclear decommissioning trust - net asset value (1)(2)

 

166,300

 

 

 

 

 

 

 

 

 

 

Unrestricted investments and other (3)

 

166

 

 

 

 

 

 

166

 

 

 

 

Derivatives - gas and power (4)

 

3,478

 

 

 

1,582

 

 

 

480

 

 

 

1,416

 

Total Financial Assets

$

245,981

 

 

$

77,619

 

 

$

646

 

 

$

1,416

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives - gas and power (4)

$

6,406

 

 

$

 

 

$

6,406

 

 

$

 

Total Financial Liabilities

$

6,406

 

 

$

 

 

$

6,406

 

 

$

 

 

 

(1)

For additional information about our nuclear decommissioning trust, see Note 8—Investments.

 

 

 

(2)

Nuclear decommissioning trust includes investments measured at net asset value per share (or its equivalent) as a practical expedient and these investments have not been categorized in the fair value hierarchy.  The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Balance Sheet.

 

(3)

Unrestricted investments and other includes investments that are related to equity securities.

 

(4)

Derivatives - gas and power represent natural gas futures contracts (Level 1 and Level 2) and financial transmission rights (Level 3).  Level 1 are indexed against NYMEX.  Level 2 are valued by ACES using observable market inputs for similar transactions.  Level 3 are valued by ACES using unobservable market inputs, including situations where there is little market activity.  Sensitivity in the market price of financial transmission rights could impact the fair value.  For additional information about our derivative financial instruments, see Note 1—Summary of Significant Accounting Policies.